Patent · US Active

Antibody-STING agonist conjugates and their use in immunotherapy

US11033635B2 · kind B2 · utility

2Cited by

5References

28Claims

0Family size

Assignees

ImmuneSensor Therapeutics, Inc. · US
The Board of Regents of the University of Texas System · US

Inventors

Zhijian Chen · Dallas, US
Heping Shi · Dallas, US
Qi Wei · Dallas, US
Chuo Chen · Dallas, US
Lijun Sun · Harvard, US
Jian Qiu · Longmont, US
Youtong Wu · Dallas, US

Key dates

Filing date	Jul 20, 2020
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Jul 20, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to, among other things, antibody-drug conjugates comprising a STING agonist cyclic di-nucleotide conjugated to an antibody, preparation methods therefor, and uses therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.